Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment

Successful qualification of Opteon™ fluid in 2CRSi server sparks broader collaboration to drive innovation in new and existing technologies across respective portfolios WILMINGTON, Del. and STRASBOURG, France, Feb. 24, 2026 /PRNewswire/ -- The Chemours Company (NYSE: CC), a global chemistry company, and 2CRSi (ISIN code: FR0013341781), a pioneer in high-performance, eco-responsible server technology, today announced a Joint Development Agreement (JDA)1 following the successful qualification of Chemours' Opteon™ two-phase immersion cooling fluid in current-generation 2CRSi servers.

PRNewsWire • 8 hours ago

Chemours' Q4 Earnings Surpass Estimates, Revenues In Line

CC posts a wider y/y loss in Q4 as sales dip 2%, but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.

Zacks Investment Research • Feb 23, 2026

Chemours' Gerardo Familiar Appointed to SEMI North America Advisory Board

Advanced Performance Materials business president to help guide SEMI's efforts supporting North America's semiconductor innovation and supply chain resilience WILMINGTON, Del., Feb. 23, 2026 /PRNewswire/ --The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced that Gerardo Familiar, President of the company's APM business, has been appointed to the SEMI North America Advisory Board (NAAB).

PRNewsWire • Feb 23, 2026

Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade)

Chemours Company is downgraded to "Hold" after a sharp rally, with shares now fairly valued around $18. CC's TSS segment benefits from Opteon adoption and future data center demand, but other units face ongoing macro headwinds. Leverage remains elevated at 4.7x; asset sales and cash flow should reduce leverage to 4x by year-end, but further progress will be slow.

Seeking Alpha • Feb 23, 2026

Why Chemours Plunged Today

Chemours met revenue expectations but missed profit expectations in the fourth quarter. The stock had roughly doubled since late November, so a pullback on anything less than perfect is no surprise.

The Motley Fool • Feb 20, 2026

Chemours Stock Tumbles After Earnings. Data-Center Cooling Couldn't Save the Quarter.

Chemours reports quarterly earnings per share of 5 cents, 2 cents lighter than Wall Street expectations.

Barrons • Feb 20, 2026

The Chemours Company (CC) Q4 2025 Earnings Call Transcript

The Chemours Company (CC) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 20, 2026

The Chemours Company Reports Fourth Quarter and Full Year 2025 Results

WILMINGTON, Del., Feb. 19, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions ("TSS"), Titanium Technologies ("TT"), and Advanced Performance Materials ("APM"), today announced its financial results for the fourth quarter and full year 2025.

PRNewsWire • Feb 19, 2026

Chemours (CC) Beats Q4 Earnings Estimates

Chemours (CC) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of breakeven. This compares to earnings of $0.11 per share a year ago.

Zacks Investment Research • Feb 19, 2026

Compared to Estimates, Chemours (CC) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Feb 20, 2026